Showing 2091-2100 of 2494 results for "".
- CheckedUp Announces Content Licensing Initiative with The American Academy of Ophthalmology to Strengthen its Patient Education Offeringshttps://modernod.com/news/checkedup-announces-content-licensing-initiative-with-the-american-academy-of-ophthalmology-to-strengthen-its-patient-education-offerings/2480213/CheckedUp announced that it has singed a content licensing agreement with the American Academy of Ophthalmology (AAO) in which CheckedUp will provide professional programming produced by AAO on its waiting room and exam room technology platforms. “Our membership has continued its unprecede
- Rayner Launches Optiesis Cohesive OVD Familyhttps://modernod.com/news/rayner-launches-optiesis-cohesive-ovd-family/2487302/Rayner announced the launch of Optiesis Cohesive, a proprietary new ophthalmic viscosurgical device (OVD), marking an expansion of its OVD portfolio and surgical product offering. According to the company, Optiesis Cohesive is
- Theialife Appoints Thomas Ruggia as President and CEOhttps://modernod.com/news/theialife-appoints-thomas-ruggia-as-president-and-ceo/2486807/Theialife announced the appointment of Thomas Ruggia as President and Chief Executive Officer. Mr. Ruggia will oversee the company’s development, operational, and corporate strategy as it approaches key milestones, including the planned initiation of phase 3 clinic
- Harrow Launches PharmaPack Direct-to-Prescriber Kits for Ophthalmic Medicationshttps://modernod.com/news/harrow-launches-pharmapack-direct-to-prescriber-kits-for-ophthalmic-medications/2485736/Harrow announced the launch of PharmaPack, a new Direct-to-Prescriber (DTP) cash-pay offering designed to expand access to affordable, FDA-approved branded ophthalmic medications. According to Harrow, by providing transparent,
- Global Study Examines Orthokeratology Lenses and Childhood Myopia Progressionhttps://modernod.com/news/global-study-examines-orthokeratology-lenses-and-childhood-myopia-progression/2485610/A new international meta-analysis has found that orthokeratology lenses can significantly slow the progression of myopia in children, offering further evidence that the approach may play an important role in addressing the growing global myopia epidemic.
- Centre for Sight Launches 'Eye Health MOT' to Support Early Detection and Long-Term Vision Carehttps://modernod.com/news/centre-for-sight-launches-eye-health-mot-to-support-early-detection-and-long-term-vision-care/2485486/Centre for Sight has launched a new 'Eye Health MOT' service for people aged 40 and over, designed to offer a comprehensive, consultant-led assessment to detect early signs of eye disease before symptoms appear. According to C
- Orbis International Appoints Kathleen Sherwin as New President and CEOhttps://modernod.com/news/orbis-international-appoints-kathleen-sherwin-as-new-president-and-ceo/2485326/Global nonprofit organization Orbis International has named Kathleen Sherwin as its new President and Chief Executive Officer, effective immediately. Ms. Sherwin arrives at Orbis with more than 25 years of leadership experience
- Oculis Prices $110 Million Financing to Accelerate Privosegtor Developmenthttps://modernod.com/news/oculis-prices-110-million-financing-to-accelerate-privosegtor-development/2484298/Oculis announced the pricing of offerings of an aggregate of 5,432,098 of its ordinary shares at a price of $20.25 per share for total gross proceeds of $110 million. The net proceeds from the financing will be used to advance and accelerate the d
- NextGen Healthcare Expands Eye Care Solutions Through Strategic Alignment with Eyefinityhttps://modernod.com/news/nextgen-healthcare-expands-eye-care-solutions-through-strategic-alignment-with-eyefinity/2484213/NextGen Healthcare said it is enhancing its suite of offerings for optometrists and ophthalmologists through a new alignment with Eyefinity, a VSP Vision company. According to NextGen, the new collaboration will d
- Iantrek Announces US Commercial Launch of AlloFlo Uveo, First Surgical Treatment Targeting the Uveoscleral Pathwayhttps://modernod.com/news/iantrek-announces-us-commercial-launch-of-alloflo-uveo-first-surgical-treatment-targeting-the-uveoscleral-pathway/2484180/Iantrek announced the official US commercial launch of AlloFlo Uveo, the first surgical treatment specifically designed to target the uveoscleral pathway. This milestone follows Iantrek’s $42 million Se